Company: PTPI
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001104659-25-025104
Chunk: 46

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 46
---
 of Common Stock will contain the same restrictive legend or notation.

<div align='center'>28</div>

Any stockholder whose share
certificate(s) representing pre-Reverse Stock Split shares of Common Stock has been lost, stolen or destroyed will only be issued
post-Reverse Stock Split Common Stock after complying with the requirements that the Company and our transfer agent customarily apply
in connection with lost, stolen or destroyed certificates.

<div align='center'>STOCKHOLDERS SHOULD NOT DESTROY STOCK CERTIFICATES REPRESENTING PRE-REVERSE
STOCK SPLIT SHARES OF COMMON STOCK AND SHOULD NOT SUBMIT ANY STOCK
CERTIFICATES REPRESENTING PRE-REVERSE STOCK SPLIT SHARES OF COMMON STOCK UNTIL
THEY ARE REQUESTED TO DO SO.</div>

Anti-Takeover Effects

In addition, we have not
proposed the Reverse Stock Split, with its corresponding increase in the authorized and unissued number of shares of Common Stock, with
the intention of using the additional shares for anti-takeover purposes, although we could theoretically use the additional shares to
make more difficult or to discourage an attempt to acquire control of the Company.

We do not believe that our
officers or directors have interests in this proposal that are different from or greater than those of any other of our stockholders.

Appraisal Rights

Under the Delaware General
Corporation Law, our stockholders are not entitled to appraisal or dissenter’s rights with respect to the Reverse Stock Split, and
we will not independently provide our stockholders with any such rights.

Regulatory Approvals

The Reverse Stock Split will
not be consummated, if at all, until after approval of the Company’s stockholders is obtained. The Company is not obligated to obtain
any governmental approvals or comply with any state or federal regulations prior to consummating the Reverse Stock Split other than the
filing of the Reverse Stock Split Charter Amendment with the Secretary of State of the State of Delaware.

Accounting Treatment of the Reverse Stock Split

If the Reverse Stock Split
is effected, the par value per share of our Common Stock will remain unchanged at $0.0001. Accordingly, on the effective date of the Reverse
Stock Split, the stated capital on the Company’s consolidated balance sheets attributable to our Common Stock will be reduced in
proportion to the size of the Reverse Stock Split ratio, and the additional paid-in capital account will be increased by the amount by
which the stated capital is reduced. Our stockholders’ equity,